Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo [4,3a][1,4] benzodiazepine (D-40tA) and its 1-methyl analogue (D-65MT).
D000284:Administration, Oral; D000374:Aggression / Q000187:drug effects; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D000932:Antiemetics / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001381:Azepines / Q000633:toxicity; D001522:Behavior, Animal / Q000187:drug effects; D001552:Benzazepines / Q000494:pharmacology*; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D002749:Chlorprothixene / Q000494:pharmacology; D003975:Diazepam / Q000494:pharmacology; D004193:Discrimination Learning / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D000882:Haplorhini; D006591:Hexobarbital / Q000494:pharmacology; D006801:Humans; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008297:Male; D008635:Mescaline / Q000037:antagonists & inhibitors; D008694:Methamphetamine / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D009043:Motor Activity / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D012110:Reserpine / Q000037:antagonists & inhibitors; D012890:Sleep / Q000187:drug effects; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D014230:Triazoles / Q000494:pharmacology / Q000633:toxicity
D000927:Anticonvulsants; D000932:Antiemetics; D001381:Azepines; D001552:Benzazepines; D009125:Muscle Relaxants, Central; D014230:Triazoles; D008694:Methamphetamine; D002707:Chlordiazepoxide; D009020:Morphine; D012110:Reserpine; D002749:Chlorprothixene; D006591:Hexobarbital; D001058:Apomorphine; D003975:Diazepam; D008635:Mescaline; D013747:Tetrabenazine